tirzepatide wada WADA just added tirzepatide (mounjaro) to the 2026 Monitoring Program WADA Adds Tirzepatide to 2026

Experts say for many, GLP-1s can be life-changing but they're not a one-size-fits-all solution, and mental health should be part of the conversation

Also new in Chapter 18: A specific code for cannabis hyperemesis syndrome and updated codes for abnormal rheumatoid factor (R76.81)

Use single-agent reninangiotensin system inhibitors at maximally tolerated doses and, when appropriate, sodium-glucose cotransporter-2 inhibitors and finerenone to slow the progression of DKD

Like the rest of this blend, the fat-loss evidence is preclinical, and human outcome data does not yet exist

Beyond its cosmetic benefits, glutathione plays a crucial role in overall health

DMello, S